While both target GLP-1 receptors, Mounjaros dual agonism enhances efficacy, especially in obese and insulin-resistant populations
Recalls & Warnings February 20, 2025 Maker of Zicam Agrees to Pay $6 Million to Settle Lawsuit Over Claims to Shorten Colds The maker of Zicam Cold Remedy products, Church & Dwight Co., Inc., has agreed to pay up to $6 million to settle a class action lawsuit that charged it with promoting the products to reduce the severity of cold symptoms and reduce the duration of colds without reliable scientific evidence
Ma J, Han Y, Yang H, Liu L, Wei Z, Wang F, et al
If you have hit a plateau, it usually means your body has adapted to where you are right now